solv cse

SoLVBL Solutions Inc. Begins Trading on the Canadian Securities Exchange Under the Symbol "SOLV"

SoLVBL Solutions Inc. (CSE: SOLV) (the "Company" or "SoLVBL") is pleased to announce that it will commence trading on the Canadian Securities Exchange under the symbol SOLV at the open of business today.

SoLVBL's vision is a world where every digital record's authenticity can be established quickly and irrefutably. SoLVBL will operate in the Cyber Security and Data authentication sectors. The world is living in an increasingly digital age with digital forgery a growing problem. SoLVBL is focused on creating trust, expeditiously, by allowing data to be authenticated before use.

Ray Pomroy, CEO of SoLVBL commented, "I am excited to share this announcement as it represents a significant milestone for SoLVBL, our team and our shareholders." Q by SoLVBL is an innovative, proprietary data authentication SaaS that uniquely features advanced cryptography for data authenticity. It offers integrity protection against data substitution or corruption (for data at rest), as well as Man-in-the-middle attacks (for data in motion). "Having led the supply chain initiatives at Unilever Canada, I know, firsthand what it takes to ensure security and data integrity. I am very proud of our team's accomplishments and look forward to delivering long-term value for all stakeholders across a variety of sectors," added Mr. Pomroy.

The cyber security market size was valued at $149.67 billion in 2020 and is projected to reach $304.91 billion by 2027, growing at a CAGR of 9.4% from 2020 to 2027. North America accounts for 45% of the global market for Cyber Security. The Data security & privacy segment is expected to outpace the total market growth for cyber security.

SoLVBL's main product offering is Q by SoLVBL, targeting the Data security and privacy segment. Q by SoLVBL operates at unprecedented speed and scalability, having a capability of processing over 150,000 transactions per second with low levels of latency. A key feature is confidentiality, as Q by SoLVBL never keep records of any data.

SoLVBL is currently pursuing the following verticals, Information attribution and authenticity (legal, digital evidence, medical, financial etc.), Pharmaceutical verification, Advertising audits and Supply chain tracing.

By using Q by SoLVB: you Create trust fast by stamping before storing and verifying before using.

For further information, please contact: Raymond Pomroy, Chief Executive Officer
15 Toronto Street, Suite 602, Toronto, Ontario, M5C2E3, www.SoLVBL.com

Email: Ray.Pomroy@SoLVBL.com Tel: 905.510.7982

The CSE has neither approved nor disapproved the contents of this press release.

NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, SoLVBL Solutions Inc. assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/75188

News Provided by Newsfile via QuoteMedia

The Conversation (0)
BlinkLab

Large-Scale Study Validates and Enhances BlinkLab’s Accuracy in Detecting Autism in Children

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism and other neurological conditions, is excited to announce results from the latest study in autism confirming high-accuracy in detecting autism in children ahead of upcoming FDA registrational study.

Keep reading...Show less
  Spectur Limited

Spectur Awarded Long Term Contract with Transport for NSW

Solar security, sensing and visual AI solutions and platforms company Spectur Limited (ASX: SP3) (Spectur or the Company) is pleased to announce the signing of a three-year contract for $787,428 with Transport for NSW (Contract No: CW2592803), with optional extensions to nine (9) years (Total price – nine year term - $2,632,284).

Keep reading...Show less
TSMC logo with chip.

Tech 5: TSMC Gets US$6.6 Billion Biden Admin Grant, Bitcoin Price Hits New All-time High

Bitcoin reached new levels this week, then paused amid speculation about how high it could go.

Meanwhile, the Biden administration finalized a multibillion-dollar arrangement to bring advanced semiconductor manufacturing back to the US, and a nuclear energy firm backed by Sam Altman announced data center supply deals.

Stay informed on the latest developments in the tech world with the Investing News Network's round-up below.

Keep reading...Show less
BlinkLab

BlinkLab Limited (ASX: BB1) – Trading Halt

Description

The securities of BlinkLab Limited (‘BB1’) will be placed in trading halt at the request of BB1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 20 November 2024 or when the announcement is released to the market.

Keep reading...Show less
BlinkLab

BlinkLab to Participate in the Landmark Monash University Autism/ADHD MAGNET Project

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for neurological conditions, is pleased to announce their participation in the landmark MAGNET (Monash Autism & ADHD Genetics and Neurodevelopment) study conducted by Monash University’s School of Psychological Sciences.

Link: https://molecularautism.biomedcentral.com/articles/10.1186/s13229-021-00457-3

Keep reading...Show less

Latest Press Releases

Related News

×